THE ROLE AND SIGNIFICANCE OF BRAIN NEUROTROPHIC FACTOR IN THE CLINICAL COURSE OF MIGRAINE DISEASE
Keywords:
migraine, headache, neurotrophic factor, attack, painAbstract
Migraine is a chronic neurological disease characterized by frequent attacks of unilateral throbbing headache, aggravated by exercise, accompanied by photophobia, phonophobia, nausea, vomiting, and in some patients even skin allodynia. Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the central and peripheral nervous system. BDNF plays an important role in the control of neuronal activity. In addition to influencing neuronal development and differentiation, BDNF also plays an important role in the modulation of pain signals.
The purpose of study: to study the role and significance of the brain-derived neurotrophic factor in the clinical course of migraine. Study of sexual changes in BMNO in migraine.
Materials and methods: 78 patients with episodic migraine aged 18 to 44 years (mean age 32.8±7.8 years) were selected for the study. The control group consisted of 30 healthy volunteers (mean age 29.9±3.7 years). All patients were diagnosed by a neurologist using the International Classification of Headache Disorders.
Conclusion: During a migraine attack, there was an increase in the concentration of BMNO in the blood serum of patients. This, in turn, leads to a decrease in the quality of life of patients with acute migraine and a decrease in the effectiveness of treatment.
References
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211.
Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614-624.;
Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63:148-158.
Buse DC, Scher AI, Dodick DW, et al. Impact of migraine on the family: Perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Proc. 2016: doi: 10.1016/j.mayocp.2016.02.013. [Epub ahead of print].
Serrano D, Manack AN, Reed ML, Buse DC, Varon SF, Lipton RB. Cost and predictors of lost productive time in chronic migraine and episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study. Value Health. 2013;16:31-38.
Laurell K, Artto V, Bendtsen L, et al. Premonitory symptoms in migraine: A cross-sectional study in 2714 persons. Cephalalgia. 2016;36:951-959.
Global, regional, and national burden of neurological disorders during 1990- 2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. (2017) 16:877–97. doi: 10.1016/S1474-4422(17)30299-5
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. (2016) 388:1545– 602. doi: 10.1016/S0140-6736(16)31678-6
Dodick DW. Migraine. Lancet. (2018) 391:1315– 30. doi: 10.1016/S0140-6736(18)304781
Ashina M. Migraine. N Engl J Med. (2020) 383:1866–76. doi: 10.1056/NEJMra1 915327
Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346(4):257–270 (Epub 2002/01/25)
Leone M, Bussone G (2009) Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol 8(8):755–764
Neurotrophins and Migraine, L.B. Martins, A.L. Teixeira, R.B. Domingues, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 2017, Elsevier, Vitamins and Hormones, Volume 104;
“Gender types of migraine” Bakhtigul Holmuratova, Nilufar Rashidova. Journal of the Neurological Sciences
Lipsky RH, Marini AM (2007) Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci 1122:130–143]
Aarse J, Herlitze S, Manahan-Vaughan D. The requirement of BDNF for hippocampal synaptic plasticity is experience-dependent. Hippocampus. 2016;26(6):739-751. https://doi.org/10.1002/hipo.22555
Quach TT, Lerch JK, Honnorat J, Khanna R, Duchemin AM. Neuronal networks in mental diseases and neuropathic pain: beyond brain derived neurotrophic factor and collapsin response mediator proteins. World Journal of Psychiatry. 2016;6(1):18-30. https://doi.org/10.5498/wjp.v6.i1.18
Hanifa Mukhsinovna HALIMOVA, Nilufar Safoyevna RASHIDOVA, Bakhtigul Nurmuhammedovna HOLMURATOVA «GENDER CHARACTERISTICS AND FEATURES OF THE COURSE OF PRIMARY HEADACHES» Journal of Biomedicine and Practice. 2021, vol. 6, issue 1, pp.64-68
Khalimova Khanifa, Rashidova Nilufar, Holmuratova Bahtigul, Rakhmatullaeva Gulnora «The importance of neurotrophical factors in the pathogenesis of primary headaches» Journal of Biomedicine and Practice. 2022, vol. 7, issue 1, pp.105-110
A.L. Allen, K.E. McCarson Estrogen increases nociception-evoked brain-derived neurotrophic factor gene expression in the female rat Neuroendocrinology, 81 (2005), pp. 193 199;
S.D. Kuipers, C.R. Bramham, Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy, Curr. Opin. Drug Discov. Devel., 9 (2006), pp. 580-586;
K. Martinowich, H. Manji, B. Lu, New insights into BDNF function in depression and anxiety, Nat. Neurosci., 10 (2007), pp. 1089-1093.
“Anxiety-depressive disorders in women with migraine” Nilufar Rashidova, Khanifa Khalimova, Gulnora Rakhmatullaeva, Bakhtigul Holmuratova,Journal of the Neurological Sciences, 2021
“The Role and Significance of Complement C3 Factor in the Clinical Course of Diabetic Polyneuropathies” H. M. Khalimova, Z. Yu. Khalimova, A. A. Khodjimetov, R. J. Matmurodov, S. M. Umirova, American Journal of Medicine and Medical Sciences 2022, 12(11): 1166-1170 DOI: 10.5923/j.ajmms.20221211.15
